Difference between revisions of "Part:BBa K2008005"
Line 8: | Line 8: | ||
− | Note: This part is a composite part, not a basic part, but it could not be | + | Note: This part is a composite part, not a basic part, but it could not be added as composite at the time of entry. |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Revision as of 16:58, 9 October 2016
pVeg->sec-TD1-KSCI-BBI
This part contains an active nonamer from the Bowman Birk Protease Inhibitor (BBI) with the addition of lysine, serine, cysteine, and isoleucine (KSCI) tag on the N-terminal end and a phenylalanine (F) tag on the C-terminal end to increase BBI solubility. A B. subtilis secretory signal peptide sequence is included to allow for secretion of the peptide directly into surrounding media. A transdermal tag (TD1, BBa_K1074000) is fused to the N-terminus of BBI to allow for diffusion of the peptide across the skin.
This coding sequence is under the control of the constitutive B. subtilis promoter pVeg (BBa_K143012) and a strong B. subtilis RBS (BBa_K780001).
Note: This part is a composite part, not a basic part, but it could not be added as composite at the time of entry.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]